Evidence map›Paper›PMID 28334068›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2017

The Dyslexia-susceptibility Protein KIAA0319 Inhibits Axon Growth Through Smad2 Signaling.

Filipa Franquinho, Joana Nogueira-Rodrigues, Joana M Duarte, Sofia S Esteves, Christin Carter-Su, Anthony P Monaco, Zoltán Molnár, Antonio Velayos-Baeza, Pedro Brites, Mónica M Sousa

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dyslexia associated geneFrontiers in cell and developmental biology · 2022
    Article
  13. Animal models of developmental dyslexia.Frontiers in neuroscience · 2022
    Review
  14. BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  15. Article
  16. Review
  17. Neuroimaging genetic associations betweenJournal of clinical and experimental neuropsychology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Filipa FranquinhoNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Joana Nogueira-RodriguesNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Joana M DuarteNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Sofia S EstevesNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Christin Carter-SuDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109-22, USA.
Anthony P MonacoThe Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, UK.
Zoltán MolnárDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford OX1 3QX, UK.
Antonio Velayos-BaezaThe Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, UK.
Pedro BritesNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
Mónica M SousaNerve Regeneration group, Instituto de Biologia Molecular e Celular - IBMC and Instituto de Inovação e Investigação em Saúde, University of Porto, 4200-135 Porto, Portugal.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTCentre for Human Genetics · GBUniversity of Michigan–Ann Arbor · USUniversity of Oxford · GB

Funding

Growth Hormone Regulation of SH2B1R01DK054222 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARTER-SU, CHRISTIN · 1999 to 2020
$7.7M
NIDDK NIH HHS R01 DK054222Wellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust 092071/Z/10/Z
6 · The paper itself

Abstract

KIAA0319 is a transmembrane protein associated with dyslexia with a presumed role in neuronal migration. Here we show that KIAA0319 expression is not restricted to the brain but also occurs in sensory and spinal cord neurons, increasing from early postnatal stages to adulthood and being downregulated by injury. This suggested that KIAA0319 participates in functions unrelated to neuronal migration. Supporting this hypothesis, overexpression of KIAA0319 repressed axon growth in hippocampal and dorsal root ganglia neurons; the intracellular domain of KIAA0319 was sufficient to elicit this effect. A similar inhibitory effect was observed in vivo as axon regeneration was impaired after transduction of sensory neurons with KIAA0319. Conversely, the deletion of Kiaa0319 in neurons increased neurite outgrowth in vitro and improved axon regeneration in vivo. At the mechanistic level, KIAA0319 engaged the JAK2-SH2B1 pathway to activate Smad2, which played a central role in KIAA0319-mediated repression of axon growth. In summary, we establish KIAA0319 as a novel player in axon growth and regeneration with the ability to repress the intrinsic growth potential of axons. This study describes a novel regulatory mechanism operating during peripheral nervous system and central nervous system axon growth, and offers novel targets for the development of effective therapies to promote axon regeneration.

Indexed as

Neuronal OutgrowthAgingAnimalsAxonsCell Adhesion MoleculesCell EnlargementCell LineCells, CulturedFemaleGanglia, SpinalHippocampusHumansJanus Kinase 2MaleMice, Inbred C57BLMice, TransgenicCell Adhesion MoleculesJanus Kinase 2KIAA0319 protein, humanKIAA0319 protein, mouseNerve Tissue ProteinsRGD1307443 protein, ratSmad2 Proteinaxon growthaxon regenerationdyslexiaKIAA0319Smad2

Identifiers

PMID28334068
PMCPMC5905272
OpenAlexW2591318540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.